The University has a strong reputation for innovation, excellence and creativity. Its strengths, in the application of research, has led to a number of major associated companies being developed. In turn, these companies benefit both Bradford and the wider region and create a focus for expertise, which is vital in the sustained drive for inward investment. Pro-active, cutting-edge research also feeds back into teaching, benefiting both students and the institution as a whole.

June 2000 saw the opening of a new £1 million plant to manufacture pharmaceuticals by means of a revolutionary new technology developed at bpd, a company set up in 1994 as a commercial spin-off from the University's School of Pharmacy. Opened by Trade and Industry Minister Stephen Byers (pictured right) at Listerhills Science Park, bpd's premises house a new process set to change the accepted method of manufacturing drugs. Many of the world's major pharmaceutical companies are customers and the University retained a significant shareholding in the company.

Mr Byers praised the work being carried out by bpd saying: "This new plant is not only a world leader in new technology for the production of pharmaceuticals, it is also a shining example of creative collaboration between university and industry and a signpost for the future.

"This is the kind of knowledge-driven new business in the region that the UK needs to keep ahead in an increasingly competitive global marketplace."

more